From WHO to GLP‑1: The week’s biggest health debates & India’s malaria challenge

In this episode of Health Wrap, we track major shifts in global health governance following the United States’ formal withdrawal from the World Health Organization, a move that could reshape international public health coordination.

We also examine fresh developments in obesity treatment, as Indian drugmakers receive regulatory clearance to manufacture and sell generic versions of semaglutide, raising questions around access, affordability, and competition in the obesity-treatment market.

The episode also looks at rising scrutiny of social media platforms over their impact on children and adolescents, with courts and lawmakers in the United States and Europe assessing whether stronger, enforceable protections are needed.

We end with India’s progress toward eliminating malaria by 2030 — reviewing gains made so far, state-level advances, and the challenges that remain in meeting this long-standing public health goal.

Presentation: Ramya Kannan and Zubeda Hamid
Production: Athira Elssa Johnson
Video and editing: Thamodharan B